Structural Formula Dobutamine Hydrochloride (Dobutamine 02)
Dobutamine Injection, Solution, Concentrate
Product Images NDC 0409-2344
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dobutamine (NDC 0409-2344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo (Dobutamine 03)
Principal Display Panel (20 mL Vial Label)
DOBUTamine Injection, USP is a medication that comes as a 20 mL single-dose flip-top vial. Each mL contains 125 mg dobutamine hydrochloride and 0.2 mg of sodium metabisulfite. It could also contain hydrochloric acid and/or sodium hydroxide for pH adjustment. The drug's packaging contains additional information about dilution, dosage, and administration. The unused portion should be discarded after 24 hours of dilution. Hospira, Inc. distributes the medication in Lake Forest, IL60045 USA, and Novaplus is a registered trademark of Vizient, Inc.*
Principal Display Panel (20 mL Vial Tray)
This is a product label or packaging information. It contains information about a medication named "Novaplus" with strength 250mg/20mL. It is distributed by Hospira, Inc in Lake Forest, Illinois. The product is made in Italy and has a barcode called GTIN. It also has a registered trademark by the name of "DMMMYYYY." The rest of the text appears to be technical information related to the product.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
